Actual compliance rate of Enhanced Recovery After Surgery protocol in laparoscopic distal gastrectomy
10.7602/jmis.2021.24.4.184
- Author:
Sang Hyeok PARK
1
;
So Hyun KANG
;
Sang Jun LEE
;
Yongjoon WON
;
Young Suk PARK
;
Sang-Hoon AHN
;
Yun-Suhk SUH
;
Do Joong PARK
;
Hyung-Ho KIM
Author Information
1. Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
- Publication Type:ORIGINAL ARTICLE
- From:Journal of Minimally Invasive Surgery
2021;24(4):184-190
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:The Enhanced Recovery After Surgery (ERAS) protocol enhances recovery rate after laparoscopic distal gastrectomy (LDG). An ERAS protocol has been applied to most patients who underwent LDG at our center. In this study, we determined the actual compliance rate of the ERAS protocol and analyzed the risk factors for noncompliance.
Methods:Medical records of 1,013 patients who underwent LDG from March 2016 to December 2017 were reviewed retrospectively. The compliance group (A) included 327 patients who were discharged within four days postoperatively. The noncompliance group (B) comprised 686 patients who were not discharged within four days postoperatively.
Results:The compliance rate of the ERAS protocol was 32.3%. Potential compliance rate was 53.2%. Most common reasons for noncompliance were fever (n = 115) and ileus (n = 111). The 30-day emergency room visit rate was significantly lower in group A than that in group B (p = 0.006). Median age, American Society of Anesthesiologists (ASA) physical status classification, operation time, and pathologic stage were significantly higher in group B than those in group A (p < 0.001, p < 0.001, p = 0.005, and p < 0.001, respectively). Risk factors for noncompliance were ASA classification of ≥III (odds ratio [OR], 2.251; p = 0.007), age of ≥70 years (OR, 1.572; p = 0.004), operation time of ≥180 minutes (OR, 1.475; p = 0.003), and pathologic stage of ≥III (OR, 2.224; p < 0.001).
Conclusion:The current ERAS protocols should be applied to patients without risk factors.
